In a significant appointment that could steer the course of ongoing litigation, a federal judge has named Christopher Seeger of Seeger Weiss LLP as lead counsel for plaintiffs in the consolidated litigation concerning the injectable contraceptive Depo-Provera and its alleged link to brain tumors. This decision was handed down by Judge M. Casey Rodgers of the US District Court for the Northern District of Florida.
Joining Seeger in this pivotal role, attorneys from Aylstock Witkin Kreis & Overholtz PLLC and Weitz & Luxenberg PC have been appointed as co-lead counsel. The case has drawn attention not only due to its potential implications for the pharmaceutical company Pfizer but also because of remarks directed at Judge Rodgers allegedly targeting his comments on female leads, a subject of controversy in conservative circles.
In an emailed statement, Seeger expressed gratitude for the judge’s confidence in his firm. He emphasized their commitment to litigating the matter to “ensure Pfizer and its subsidiaries are held accountable,” underscoring the rigorous approach expected in addressing substantial public health concerns raised by the litigation.
For further details, the full article provides in-depth coverage of the legal proceedings and the strategies expected to unfold in the court.